VEGFA and myocardial infarction: SXNI activated the VEGF-A/VEGFR2 and VEGF-C/VEGFR3 signaling pathways, thereby promoting post-MI angiogenesis and lymphangiogenesis, consequently decreasing cardiac edema, inflammation, and dysfunction.